India’s pharmaceutical MSMEs must comply with WHO’s Good Manufacturing Practices (GMP) to expand globally. The Health Ministry is pushing for upgraded manufacturing standards, regulatory reforms, and quality control. This initiative strengthens India’s generic drug exports, making them more competitive in international markets while improving healthcare standards.
India’s pharmaceutical MSMEs must comply with WHO’s Good Manufacturing Practices (GMP) to expand globally. The Health Ministry is pushing for upgraded manufacturing standards, regulatory reforms, and quality control. This initiative strengthens India’s generic drug exports, making them more competitive in international markets while improving healthcare standards.